Abstract
Pioglitazone and sitagliptin are potential alternative second-line agents in patients who particularly need to avoid hypoglycaemia (e.g. people working on scaffolding or at heights).
NICE Clinical Guideline 87 – The Management of Type 2 Diabetes www.nice.org.uk/nicemedia/live/12165/44322/44322.pdf